BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21985849)

  • 21. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage I seminoma: what should a practicing uro-oncologist do in 2009?
    Skliarenko J; Vesprini D; Warde P
    Int J Urol; 2009 Jun; 16(6):544-51. PubMed ID: 19453548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
    Melchior D; Hammer P; Fimmers R; Schüller H; Albers P
    Anticancer Res; 2001; 21(4B):2989-93. PubMed ID: 11712799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alternatives to the radiotherapy of stage I testicular seminoma].
    Paule B
    Bull Cancer; 2005 Mar; 92(3):267-71. PubMed ID: 15820921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
    Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
    Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
    Cooper DE; L'esperance JO; Christman MS; Auge BK
    J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboplatin in clinical stage I seminoma: too much and too little at the same time.
    Bosl GJ; Patil S
    J Clin Oncol; 2011 Mar; 29(8):949-52. PubMed ID: 21282532
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience of the treatment for clinical Stage-1 seminoma over a period of 10 years].
    Zhang XQ; Liu ZW; Zhou FJ; Han H; Qin ZK; Ye YL; Li YH; Hou GL; Zhang ZL
    Chin J Cancer; 2010 Jan; 29(1):98-101. PubMed ID: 20038319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of radiotherapy for 230 patients with stage I-II seminomas.
    Hültenschmidt B; Budach V; Genters K; Sack H
    Strahlenther Onkol; 1996 Apr; 172(4):186-92. PubMed ID: 8623080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of care in the management of seminoma stage I: results from a European survey.
    Vossen CY; Horwich A; Daugaard G; van Poppel H; Osanto S
    BJU Int; 2012 Aug; 110(4):524-31. PubMed ID: 22409585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage I seminoma: adjuvant treatment is effective but is it necessary?
    Chung P; Warde P
    J Natl Cancer Inst; 2011 Feb; 103(3):194-6. PubMed ID: 21212383
    [No Abstract]   [Full Text] [Related]  

  • 37. Surveillance in stage I testicular seminoma.
    Chung P; Warde P
    Urol Oncol; 2006; 24(1):75-9. PubMed ID: 16414499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options following orchiectomy for stage I seminoma.
    Lawrentschuk N; Fleshner NE
    Oncology (Williston Park); 2009 Aug; 23(9):749-53. PubMed ID: 19777758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage II seminomas and nonseminomas.
    Chung PW; Bedard P
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):529-41,viii. PubMed ID: 21570607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma.
    Domont J; Massard C; Patrikidou A; Bossi A; de Crevoisier R; Rose M; Wibault P; Fizazi K
    Urol Oncol; 2013 Jul; 31(5):697-705. PubMed ID: 21665493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.